A high‐throughput strategy for protein profiling in cell microarrays using automated image analysis
暂无分享,去创建一个
J. Kononen | F. Pontén | M. Uhlén | C. Kampf | A. Asplund | P. Nilsson | A. Andersson | C. Asplund | M. Björklund | A. Persson | Anna Sköllermo | S. Strömberg | K. Wester | M. Björklund | P. Nilsson
[1] E B Cox,et al. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. , 1985, Archives of pathology & laboratory medicine.
[2] Tristan J. Vaughan,et al. Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display Library , 1996, Nature Biotechnology.
[3] J. Kononen,et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.
[4] D. Botstein,et al. The transcriptional program in the response of human fibroblasts to serum. , 1999, Science.
[5] M. Rajeevan,et al. Copyright © American Society for Investigative Pathology and the Association for Molecular Pathology Validation of Array-Based Gene Expression Profiles by Real-Time (Kinetic) RT-PCR , 2022 .
[6] E. Frenkel,et al. Assessment of HER-2/neu status in breast cancer. Automated Cellular Imaging System (ACIS)-assisted quantitation of immunohistochemical assay achieves high accuracy in comparison with fluorescence in situ hybridization assay as the standard. , 2001, American journal of clinical pathology.
[7] Stephen G Oliver,et al. Dynamics of Protein Turnover, a Missing Dimension in Proteomics* , 2002, Molecular & Cellular Proteomics.
[8] Carlos Caldas,et al. Molecular Classification of Breast Carcinomas Using Tissue Microarrays , 2003, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[9] M. Gerstein,et al. Comparing protein abundance and mRNA expression levels on a genomic scale , 2003, Genome Biology.
[10] David L Rimm,et al. Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome. , 2003, Cancer research.
[11] Ximing J. Yang,et al. Alpha‐methylacyl‐CoA racemase: a multi‐institutional study of a new prostate cancer marker , 2004, Histopathology.
[12] R. Halaban,et al. Automated Quantitative Analysis of HDM2 Expression in Malignant Melanoma Shows Association with Early-Stage Disease and Improved Outcome , 2004, Cancer Research.
[13] John McCafferty,et al. Expression profiling by high-throughput immunohistochemistry. , 2004, Journal of immunological methods.
[14] D. Rimm,et al. Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis. , 2005, Journal of the National Cancer Institute.
[15] F. Pontén,et al. Antibody-based Proteomics for Human Tissue Profiling , 2005, Molecular & Cellular Proteomics.
[16] S. Pinder,et al. E‐cadherin expression in invasive non‐lobular carcinoma of the breast and its prognostic significance , 2005, Histopathology.
[17] F. Pontén,et al. Towards a human proteome atlas: High‐throughput generation of mono‐specific antibodies for tissue profiling , 2005, Proteomics.
[18] Erik K. Malm,et al. A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics* , 2005, Molecular & Cellular Proteomics.
[19] F. Pontén,et al. Analysis of Protein Expression in Cell Microarrays: A Tool for Antibody-based Proteomics , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[20] Sophia Hober,et al. A human protein atlas based on antibody proteomics. , 2006, Current opinion in molecular therapeutics.
[21] F. Pontén,et al. Antibody-based tissue profiling as a tool for clinical proteomics , 2004, Clinical Proteomics.